使用TRV椅治疗良性阵发性位置性眩晕。
Management of Benign Paroxysmal Positional Vertigo with the TRV Chair.
文献信息
| PMID | 42732220 |
|---|---|
| 原文 | 在 PubMed 查看原文 ↗ |
| 发表日期 | 2026 |
| 作者 | Sandra Krzywdzińska |
| 作者单位 | Department of Otolaryngology with Division of Cranio-Maxillo-Facial Surgery, Military Institute of Medicine-National Research Institute, Warsaw, Poland. |
| 期刊 | International archives of otorhinolaryngology |
| SCI 分区 | Q3 |
| IF | 1.4 |
| 研究类型 | 临床研究 · 临床 |
| 所属专科 | 耳科 |
中文摘要
引言： 尽管对良性阵发性位置性眩晕（BPPV）的认识不断提高，但在非典型或细微病例中建立准确诊断仍然是一个临床挑战，尤其是当标准位置性操作结果为阴性时。
目的： 评估TRV椅（Interacoustics A/S）在临床病史提示BPPV但常规诊断操作结果阴性的患者中的诊断和治疗效果。
方法： 共有40名眩晕症状提示BPPV且标准位置性测试结果阴性的患者接受了使用TRV椅的评估和治疗。在干预前后使用眩晕障碍量表（DHI；总分和各子量表）、眩晕症状量表（VSS）和Berg平衡量表（BBS）评估症状严重程度和功能影响。
结果： TRV椅干预后观察到显著改善。平均DHI总分从40.3降至22.2（p < 0.0001），功能（17.6-7.1）、情绪（13.5-8.8）和躯体（17.1-5.8）子量表均有改善（所有p < 0.0001）。VSS评分从17.7改善至10.4（p < 0.0001），BBS评分从51.8增加至53.6（p < 0.0001）。
结论： TRV椅似乎是疑似BPPV但标准测试未确认的患者的有效诊断和治疗工具。其应用可能增强非典型病例的管理；然而，需要进一步研究以定义最佳临床方案并确认长期疗效。
英文摘要
INTRODUCTION: Despite the growing awareness regarding benign paroxysmal positional vertigo (BPPV), establishuing an accurate diagnosis in atypical or subtle cases remains a clinical challenge, especially when standard positional maneuvers yield negative results.
OBJECTIVE: To evaluate the effectiveness of the TRV Chair (Interacoustics A/S) in the diagnosis and treatment of patients with a clinical history suggestive of BPPV but negative findings on conventional diagnostic maneuvers.
METHODS: A total of 40 patients with vertigo symptoms suggestive of BPPV and negative results on standard positional tests underwent evaluation and therapy using the TRV Chair. Symptom severity and functional impact were assessed before and after the intervention using the Dizziness Handicap Inventory (DHI; total and subscales), the Vertigo Symptom Scale (VSS), and the Berg Balance Scale (BBS).
RESULTS: Significant improvements were observed following the TRV Chair intervention. The mean total DHI score decreased from 40.3 to 22.2 ( p < 0.0001), with improvements in the functional (17.6-7.1), emotional (13.5-8.8), and physical (17.1-5.8) subscales ( p < 0.0001 for all). The VSS scores improved from 17.7 to 10.4 ( p < 0.0001), and the BBS scores increased from 51.8 to 53.6 ( p < 0.0001).
CONCLUSION: The TRV Chair appears to be an effective diagnostic and therapeutic tool for patients with suspected BPPV not confirmed by standard tests. Its application may enhance the management of atypical cases; however, further studies are warranted to define optimal clinical protocols and confirm the long-term efficacy.